scispace - formally typeset
E

Eugen Faist

Researcher at Ludwig Maximilian University of Munich

Publications -  117
Citations -  9140

Eugen Faist is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Sepsis & Cytokine. The author has an hindex of 36, co-authored 117 publications receiving 8793 citations.

Papers
More filters
Journal ArticleDOI

modulation Of Immune Response By Blood Transfusion : evidence For A Differential Effect Of Allogeneic And Autologous Blood In Colorectal Cancer Surgery

TL;DR: The hypothesis that autologous blood transfusion does not contain immunologically neutral effects of allogeneic blood, but itself exerts an immunomodulatory effect is supported.
Journal ArticleDOI

Perioperative Recombinant Human Granulocyte Colony-Stimulating Factor (Filgrastim) Treatment Prevents Immunoinflammatory Dysfunction Associated with Major Surgery

TL;DR: Filgrastim treatment reinforces innate immunity, enabling better prevention of infection, and this unique combination of hematopoietic, anti-inflammatory and anti-infectious effects on the innate immune system warrants further study of clinical efficacy and sepsis prophylaxis.
Journal ArticleDOI

Hemofiltrate from patients with severe sepsis and depressed left ventricular contractility contains cardiotoxic compounds.

TL;DR: Significantly higher filtration rates may be required to improve left ventricular contractility in patients with sepsis by hemofiltration, which induced significant cardiotoxic effects in rat cardiomyocytes whereas UFh showed no cardiotoxicity.
Journal ArticleDOI

Postburn constitutional changes in T-cell reactivity occur in CD8+ rather than in CD4+ cells.

TL;DR: The data corroborate that major burn trauma will induce a significant shift of cytokine response toward the TH2 direction and demonstrate that the CD8+ rather than the CD4+ phenotype is the crucial cell for the polarization toward a TH2-driven immune response.
Journal ArticleDOI

Immunomodulatory therapy with thymopentin and indomethacin. Successful restoration of interleukin-2 synthesis in patients undergoing major surgery.

TL;DR: This study clearly demonstrates that the combined Indo/TP-5 therapy is superior to single Indo administration and can adequately preserve and/or restore intact M phi T-cell interaction and thus appears to be a feasible approach to maintain normal host defense activity in traumatized individuals.